Alexander Siebenhüner

Author

Also Known As

A Siebenhüner, A. Siebenhüner, A.R. Siebenhuner, A.R. Siebenhüner, Alexander R Siebenhüner, Alexander R. Siebenhüner, Alexander Reinhard Siebenhüner, Alexander Siebenhüner, Pierre-Alain Clavien, Siebenhüner, Alexander

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Zurich University of Zurich University Hospital of Bern University of Bern Medical University of Vienna

About

Alexander Siebenhüner is an author at University Hospital of Zurich specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	509
2	Immunology	2	2	408
3	Health Sciences	1	1	19
4	Cell Biology	1	1	352
5	Hepatology	1	1	56

Alexander Siebenhüner

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
NASH limits anti-tumour surveillance in immunotherapy-treated HCC Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Nature	2021	1.2K
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer Florian Posch, Karīna Siliņa, Sebastian Leibl, OncoImmunology ImmunologyPathologyIii Colorectal CancerTls NumbersImmunotherapy	2017	352
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Journal of Hepatology	2021	284
Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin Marcel Schneider, Janina Eden, Basile Pache, Annals of Surgery	2018	104
Vegetarian or gluten‐free diets in patients with inflammatory bowel disease are associated with lower psychological well‐being and a different gut microbiota, but no beneficial effects on the course of the disease Philipp Schreiner, Bahtiyar Yılmaz, Jean‐Benoît Rossel, United European Gastroenterology Journal	2019	100
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases Alexander Siebenhüner, Ulrich Güller, René Warschkow BMC Cancer	2020	90
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy Christian Hirt, Tijmen H. Booij, Linda Grob, Cell Genomics	2022	76
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study Cédric Nesti, Konstantin Bräutigam, Marta Benavent, The Lancet Oncology Neuro-oncologyEndocrine OncologySurgical OncologyHemicolectomy Versus AppendectomySurgical Pathology	2023	64
Assessing the impact of COVID-19 on liver cancer management (CERO-19) Sergio Muñoz, Víctor Sapena, Alejandro Forner, JHEP Reports	2021	60
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma Bernhard Scheiner, Daniel Roessler, Samuel Phen, JHEP Reports HepatologyMedicineImmunologyPathologyImmune Checkpoint Inhibitor	2022	56

Page 1